| This division is focused on offering a comprehensive product basket covering Anti-Asthma, Allergy, Respiratory Tract infections and Chronic Obstructive Pulmonary Disorders (COPD). With eight new brands launched during the year, it continues to garner market share in the Indian Anti-Asthma market, registering a growth of 34% in FY 2010 as against the market growth of 21%.
Key Products : Lupin Respira
|
Product |
Therapeutic segment |
Product Rank in the relevant segment |
|
L-CIN |
Levofloxacn |
1 |
|
Esiflo |
Salmeterol+Fluticasone |
2 |
|
Budamate |
Formoteral+Budesonide |
2 |
|
Budate |
Budesonide |
2 |
|
Tiomate |
Tiotropium+Formoteral |
2 |
|
Telekast |
Montelukast |
3 |
|
Salbair |
Salbutamol |
3 |
| 
